News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,727 Results
Type
Article (17575)
Company Profile (120)
Press Release (165032)
Section
Business (58257)
Career Advice (942)
Deals (9367)
Drug Delivery (36)
Drug Development (23437)
Employer Resources (70)
FDA (2337)
Job Trends (4237)
News (92262)
Policy (5783)
Tag
2024 BioCapital Digital (3)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (483)
Accelerated approval (1)
Adcomms (13)
Allergies (19)
Alliances (16221)
ALS (32)
Alzheimer's disease (425)
Antibody-drug conjugate (ADC) (72)
Approvals (2304)
Artificial intelligence (94)
Autoimmune disease (8)
Automation (4)
Bankruptcy (81)
Best Places to Work (2895)
BIOSECURE Act (18)
Biosimilars (23)
Biotechnology (111)
Bladder cancer (24)
Brain cancer (13)
Breast cancer (77)
Cancer (736)
Cardiovascular disease (48)
Career advice (757)
Career pathing (19)
CAR-T (87)
Cell therapy (244)
Cervical cancer (6)
Clinical research (18555)
Collaboration (378)
Compensation (83)
Complete response letters (11)
COVID-19 (745)
CRISPR (15)
C-suite (122)
Cystic fibrosis (40)
Data (616)
Denatured (5)
Depression (19)
Diabetes (57)
Diagnostics (1071)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (59)
Drug pricing (22)
Drug shortages (2)
Duchenne muscular dystrophy (29)
Earnings (15817)
Editorial (13)
Employer branding (8)
Employer resources (68)
Events (31204)
Executive appointments (326)
FDA (2602)
Featured Employer (22)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (322)
Gene editing (44)
Generative AI (12)
Gene therapy (166)
GLP-1 (259)
Government (624)
Grass and pollen (1)
Guidances (9)
Healthcare (2393)
Huntington's disease (18)
IgA nephropathy (10)
Immunology and inflammation (57)
Indications (10)
Infectious disease (796)
Inflammatory bowel disease (65)
Inflation Reduction Act (3)
Influenza (19)
Intellectual property (37)
Interviews (138)
IPO (4105)
IRA (13)
Job creations (1472)
Job search strategy (702)
Kidney cancer (4)
Labor market (17)
Layoffs (160)
Leadership (10)
Legal (1186)
Liver cancer (16)
Lung cancer (85)
Lymphoma (53)
Machine learning (2)
Management (22)
Manufacturing (128)
MASH (20)
Medical device (683)
Medtech (684)
Mergers & acquisitions (5440)
Metabolic disorders (204)
Multiple sclerosis (28)
NASH (8)
Neurodegenerative disease (42)
Neuropsychiatric disorders (13)
Neuroscience (625)
NextGen: Class of 2025 (1444)
Non-profit (452)
Northern California (816)
Now hiring (16)
Obesity (113)
Opinion (172)
Ovarian cancer (29)
Pain (29)
Pancreatic cancer (23)
Parkinson's disease (43)
Partnered (8)
Patents (68)
Patient recruitment (25)
Peanut (12)
People (22072)
Pharmaceutical (15)
Phase I (7214)
Phase II (8857)
Phase III (4984)
Pipeline (360)
Podcasts (29)
Policy (52)
Postmarket research (306)
Preclinical (2921)
Press Release (61)
Prostate cancer (28)
Psychedelics (18)
Radiopharmaceuticals (81)
Rare diseases (163)
Real estate (2436)
Recruiting (35)
Regulatory (4478)
Reports (18)
Research institute (514)
Resumes & cover letters (152)
RNA editing (1)
RSV (12)
Schizophrenia (23)
Series A (77)
Series B (39)
Service/supplier (6)
Sickle cell disease (22)
Southern California (752)
Special edition (9)
Sponsored (11)
Startups (1781)
State (1)
Stomach cancer (5)
Supply chain (18)
The Weekly (24)
United States (6748)
Vaccines (212)
Venture capitalists (28)
Webinars (9)
Weight loss (81)
Women's health (9)
Worklife (5)
Date
Today (64)
Last 7 days (288)
Last 30 days (1105)
Last 365 days (12494)
2025 (2199)
2024 (12654)
2023 (13209)
2022 (16051)
2021 (16966)
2020 (13193)
2019 (9509)
2018 (7541)
2017 (8984)
2016 (8118)
2015 (9419)
2014 (9737)
2013 (9459)
2012 (6090)
2011 (6455)
2010 (5841)
Location
Africa (325)
Alabama (26)
Alaska (3)
Arizona (40)
Arkansas (2)
Asia (13428)
Australia (2674)
California (1905)
Canada (644)
China (166)
Colorado (36)
Connecticut (80)
Delaware (32)
Europe (30141)
Florida (205)
Georgia (29)
Idaho (13)
Illinois (124)
India (8)
Indiana (99)
Iowa (2)
Japan (50)
Kansas (16)
Kentucky (4)
Louisiana (3)
Maine (2)
Maryland (290)
Massachusetts (1511)
Michigan (71)
Minnesota (110)
Missouri (14)
Montana (8)
Nebraska (4)
Nevada (8)
New Hampshire (6)
New Jersey (508)
New Mexico (11)
New York (488)
North Carolina (336)
North Dakota (4)
Northern California (816)
Ohio (50)
Oklahoma (6)
Oregon (7)
Pennsylvania (402)
Puerto Rico (2)
Rhode Island (7)
South America (401)
South Carolina (2)
Southern California (752)
Tennessee (18)
Texas (218)
Utah (26)
Virginia (13)
Washington D.C. (16)
Washington State (304)
Wisconsin (11)
182,727 Results for "sartorius stedim biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
November 22, 2024
·
3 min read
Business
Preliminary results 2022 of Sartorius Stedim Biotech
Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.
January 26, 2023
·
11 min read
Nine-month results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, closed the first nine months of 2022 with double-digit sales revenue and earnings growth and specified its outlook for the current fiscal year.
October 19, 2022
·
10 min read
Business
Half-year results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, increased sales revenue and earnings with double-digit growth rates in the first half of 2022 and confirmed its full-year outlook.
July 21, 2022
·
9 min read
Business
First-quarter results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period.
April 21, 2022
·
9 min read
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Business
Nine-month results of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, has continued to grow dynamically and profitably.
October 20, 2021
·
11 min read
Preliminary results 2021 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, closed fiscal 2021 with exceptionally strong growth and a jump in profitability due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions.
January 27, 2022
·
14 min read
Deals
Sartorius Stedim Biotech completes acquisition of Novasep’s chromatography division
Sartorius Stedim Biotech, a leading partner of the biopharma industry, announced that it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission.
February 8, 2022
·
3 min read
Legal
Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug
Back in 2023, Novo Nordisk committed up to $1.3 billion for a hypertension and kidney disease drug from KBP Biosciences. Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree.
February 18, 2025
·
1 min read
·
Annalee Armstrong
1 of 18,273
Next
